Mamu-A*08 & B2M Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Pozetaldogene ormesparvovec | SBT-101 | Phase 2 Clinical | SwanBio Therapeutics Ltd | Adrenoleukodystrophy | Details |
| TYF-ABCD1 | TYF-ABCD1 | Clinical | Shenzhen Geno-Immune Medical Institute | Adrenoleukodystrophy | Details |
Marketed Drug Information
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Elivaldogene autotemcel | Approved | Bluebird Bio Inc, Inserm | Lenti-D, Skysona | United States | Adrenoleukodystrophy | Bluebird Bio Inc | 2021-07-27 | Adrenoleukodystrophy | Details |